Skip to main content

Tilray Inc(TLRY-T)
TSX

Today's Change
Real-Time Last Update

Tilray Brands: Top 10 Undervalued Growth Stocks on TSX (TLRY)

AI-generated - The Globe and Mail - Fri Apr 5, 7:54AM CDT

Tilray Brands is now ranked among the top 10 undervalued small cap growth stocks on the Toronto Stock Exchange (TSX).

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)
  • Small, micro and nano group market capitalization (<10B)

Stocks in this category that have grown their revenue significantly in their latest quarterly report. They are held primarily for capital appreciation but do present downside risk. Growth stocks are always of interest to investors as they present upside opportunity. Stocks that are both growing their quarterly revenue and showing as undervalued are of special interest as these two factors are important when looking for prospects.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
U-USprott Physical Uranium20.8540.7919.94 (95.6%)832915194.80.02.0
LSPDLightspeed Commerce18.7327.728.99 (48.0%)6175942888.10.00.0
ACAir Canada19.7627.768.00 (40.5%)24286707429.80.03.3
FFH-UFairfax Finl Hldgs903.321179.82276.50 (30.6%)22588.50.05.2
FIH-UFairfax India Holdings14.9717.382.41 (16.1%)326372048.20.05.5
PHYS-USprott Physical Gold17.7920.332.54 (14.3%)48417120.20.09.8
TLRYTilray Brands3.624.100.48 (13.3%)30178632645.40.00.0
CLSCelestica65.1373.558.42 (12.9%)6281747835.10.023.7
ELDEldorado Gold19.9822.222.24 (11.2%)4195293902.70.027.3
CURACuraleaf Holdings7.117.840.73 (10.2%)5840425148.50.00.0
U-UNSprott Physical Uranium28.6331.462.83 (9.9%)8561707133.20.02.0
TIXTTELUS Intl11.4712.581.11 (9.7%)1480933280.40.047.0
CAECAE27.1029.452.35 (8.7%)5161089006.80.031.5
BLCOBausch & Lomb22.0523.391.34 (6.1%)26427728.50.00.0
EQXEquinox Gold8.408.850.45 (5.4%)7085712656.90.068.8
BBD-ABombardier57.6160.613.00 (5.2%)58975629.70.09.0
ATSATS44.6146.872.26 (5.1%)2606574442.40.027.2
BBD-BBombardier57.7360.582.85 (4.9%)4010005641.40.09.1
BHCBausch Health Companies13.6314.260.63 (4.6%)3721054973.60.00.0
IMGIamgold4.905.100.20 (4.0%)12249692374.50.020.1
SHOPShopify101.37102.260.89 (0.9%)2439862131326.00.0747.3
BBBlackBerry3.923.940.02 (0.6%)27148472502.80.00.0
SCRStrathcona Resources31.7031.700.00 (0.0%)616836336.80.010.8
DMLDenison Mines2.892.88-0.01 (-0.3%)16509302468.00.028.9
DAYDayforce87.2086.37-0.83 (-1.0%)656513821.20.0183.7

All data provided as of April 05, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Companies included above have not paid a dividend in the last 12-months.

Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.

Tilray Brands is listed under TLRY on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

More from The Globe